ShengDa Biological Pharmaceutical Expects Earnings of RMB 26-36 Million in 2024, Returning to Profitability Year-on-Year
Continue reading with Effamall membership.
Already a member? Login here.
Tag:
Copy Link
<Prev
Next>
<Prev
Next>
